EXAS241220C60000
- 0.05
- -0.03-37.50%
Exact Sciences Newsroom
Analysts Are Bullish on These Healthcare Stocks: Exact Sciences (EXAS), Neurocrine (NBIX)
Exact Sciences Is Maintained at Buy by B of A Securities
BofA Securities Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $72
10 BofA U.S. Options Overwriting Ideas
Express News | Exact Sciences Corp : Leerink Partners Raises Target Price to $95 From $70
TD Cowen Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $86
Exact Sciences (EXAS) Gets a Buy From TD Cowen
AAPA Awarded Grant From Exact Sciences to Improve Colorectal Cancer Screening Rates
Exact Sciences Corporation's (NASDAQ:EXAS) Shares Lagging The Industry But So Is The Business
Exact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Exact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)
Exact Sciences and Lil Jon Partner on "Get Low #2" Campaign to Encourage Colon Cancer Screening
Trending Stocks This Week as Holiday Season Begins With Thanksgiving Break
US stocks mining | Nuclear energy stocks collectively rise! CEG's annual increase is nearly 130%; aerospace stocks celebrate together! SpaceX's formidable rival Rocket Lab has surged over 360% this year.
Hundred-billion collaboration agreement finalized! Biotechnology company sarepta therapeutics surged nearly 14% overnight, approaching a three-month high; Medical reimbursement limit increased! Medical diagnostic company exact sciences rose 9% last night.
What 19 Analyst Ratings Have To Say About Exact Sciences
Exact Sciences Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $86
Exact Sciences Is Maintained at Buy by BTIG
Why Is Exact Sciences Stock Trading Higher On Monday?
Exact Sciences Analyst Ratings